Beta Cat Pharmaceuticals is founded in 2010. The company operates in the Hospitals & Healthcare, Medical Practices sector.
Beta Cat Pharmaceuticals specializes in Beta catenin modulation, Cancer stem cell pathway research, APC/WNT pathway analysis, Compounds degradation in the cytoplasm, and offers services including Compounds targeting beta catenin, Translational phase compounds.